Massachusetts Financial Services Co. MA Has $102.47 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Massachusetts Financial Services Co. MA increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 31.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,310,631 shares of the company's stock after purchasing an additional 312,088 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.29% of GE HealthCare Technologies worth $102,465,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. CoreFirst Bank & Trust purchased a new position in shares of GE HealthCare Technologies in the 4th quarter worth $25,000. Runnymede Capital Advisors Inc. bought a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at about $28,000. Continuum Advisory LLC increased its position in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after purchasing an additional 168 shares during the period. Bank of Jackson Hole Trust bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $32,000. Finally, OFI Invest Asset Management purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at about $34,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 6.6 %

GEHC traded down $4.27 during trading on Thursday, reaching $60.71. The company had a trading volume of 1,673,932 shares, compared to its average volume of 3,084,847. The business's fifty day moving average price is $82.73 and its 200 day moving average price is $84.47. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a market cap of $27.76 billion, a P/E ratio of 13.99, a PEG ratio of 3.19 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be paid a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.23%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.23%.

Analyst Ratings Changes

GEHC has been the subject of several recent analyst reports. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup increased their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. Finally, The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and increased their price target for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $97.73.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.